{"lastUpdatedAt": 1611174672263, "totalPosts": {"label": "Total Posts", "value": 132}, "totalComments": {"label": "Total Comments", "value": 7356}, "postRate": {"title": "Post Rate", "data": [{"label": "2021-01-18T01:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T02:00:00.000+05:30", "value": 6}, {"label": "2021-01-18T03:00:00.000+05:30", "value": 3}, {"label": "2021-01-18T04:00:00.000+05:30", "value": 3}, {"label": "2021-01-18T06:00:00.000+05:30", "value": 2}, {"label": "2021-01-18T07:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T08:00:00.000+05:30", "value": 2}, {"label": "2021-01-18T09:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T10:00:00.000+05:30", "value": 2}, {"label": "2021-01-18T11:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T13:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T14:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T17:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T18:00:00.000+05:30", "value": 2}, {"label": "2021-01-18T19:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T20:00:00.000+05:30", "value": 3}, {"label": "2021-01-18T21:00:00.000+05:30", "value": 1}, {"label": "2021-01-18T22:00:00.000+05:30", "value": 4}, {"label": "2021-01-18T23:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T00:00:00.000+05:30", "value": 6}, {"label": "2021-01-19T01:00:00.000+05:30", "value": 1}, {"label": "2021-01-19T02:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T03:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T04:00:00.000+05:30", "value": 4}, {"label": "2021-01-19T06:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T07:00:00.000+05:30", "value": 3}, {"label": "2021-01-19T08:00:00.000+05:30", "value": 3}, {"label": "2021-01-19T09:00:00.000+05:30", "value": 3}, {"label": "2021-01-19T10:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T12:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T13:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T15:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T17:00:00.000+05:30", "value": 2}, {"label": "2021-01-19T18:00:00.000+05:30", "value": 6}, {"label": "2021-01-19T19:00:00.000+05:30", "value": 5}, {"label": "2021-01-19T20:00:00.000+05:30", "value": 4}, {"label": "2021-01-19T21:00:00.000+05:30", "value": 4}, {"label": "2021-01-19T22:00:00.000+05:30", "value": 5}, {"label": "2021-01-19T23:00:00.000+05:30", "value": 3}, {"label": "2021-01-20T00:00:00.000+05:30", "value": 6}, {"label": "2021-01-20T01:00:00.000+05:30", "value": 4}, {"label": "2021-01-20T02:00:00.000+05:30", "value": 4}, {"label": "2021-01-20T03:00:00.000+05:30", "value": 6}, {"label": "2021-01-20T04:00:00.000+05:30", "value": 2}, {"label": "2021-01-20T05:00:00.000+05:30", "value": 6}, {"label": "2021-01-20T07:00:00.000+05:30", "value": 1}, {"label": "2021-01-20T08:00:00.000+05:30", "value": 2}]}, "commentRate": {"title": "Comment Rate", "data": [{"label": "2021-01-19T23:00:00.000+05:30", "value": 216}, {"label": "2021-01-20T00:00:00.000+05:30", "value": 527}, {"label": "2021-01-20T01:00:00.000+05:30", "value": 633}, {"label": "2021-01-20T02:00:00.000+05:30", "value": 418}, {"label": "2021-01-20T03:00:00.000+05:30", "value": 340}, {"label": "2021-01-20T04:00:00.000+05:30", "value": 289}, {"label": "2021-01-20T05:00:00.000+05:30", "value": 233}, {"label": "2021-01-20T06:00:00.000+05:30", "value": 160}, {"label": "2021-01-20T07:00:00.000+05:30", "value": 164}, {"label": "2021-01-20T08:00:00.000+05:30", "value": 182}, {"label": "2021-01-20T09:00:00.000+05:30", "value": 164}, {"label": "2021-01-20T10:00:00.000+05:30", "value": 113}, {"label": "2021-01-20T11:00:00.000+05:30", "value": 86}, {"label": "2021-01-20T12:00:00.000+05:30", "value": 110}, {"label": "2021-01-20T13:00:00.000+05:30", "value": 60}, {"label": "2021-01-20T14:00:00.000+05:30", "value": 106}, {"label": "2021-01-20T15:00:00.000+05:30", "value": 95}, {"label": "2021-01-20T16:00:00.000+05:30", "value": 131}, {"label": "2021-01-20T17:00:00.000+05:30", "value": 219}, {"label": "2021-01-20T18:00:00.000+05:30", "value": 343}, {"label": "2021-01-20T19:00:00.000+05:30", "value": 404}, {"label": "2021-01-20T20:00:00.000+05:30", "value": 631}, {"label": "2021-01-20T21:00:00.000+05:30", "value": 513}, {"label": "2021-01-20T22:00:00.000+05:30", "value": 330}, {"label": "2021-01-20T23:00:00.000+05:30", "value": 328}, {"label": "2021-01-21T00:00:00.000+05:30", "value": 285}, {"label": "2021-01-21T01:00:00.000+05:30", "value": 275}, {"label": "2021-01-21T02:00:00.000+05:30", "value": 1}]}, "commentSentiments": {"title": "Comment Sentiments", "data": [{"name": "neutral", "value": 3225}, {"name": "positive", "value": 3021}, {"name": "negative", "value": 1110}]}, "postSentiments": {"title": "Post Sentiments", "data": [{"name": "neutral", "value": 81}, {"name": "positive", "value": 42}, {"name": "negative", "value": 9}]}, "topStocks": {"title": "Top stocks", "data": [{"label": "ITRM", "value": 10}, {"label": "DGLY", "value": 10}, {"label": "ATOS", "value": 11}, {"label": "SNDL", "value": 13}, {"label": "GEVO", "value": 14}, {"label": "PT", "value": 22}, {"label": "MOTS", "value": 22}, {"label": "BNGO", "value": 29}, {"label": "ZYXI", "value": 114}]}, "stockRatings": {"title": "Stock Ratings", "data": {"ITRM": {}, "DGLY": {"score": {"P/B": 3, "ROA": 2, "DCF": 3, "P/E": 3, "ROE": 5, "D/E": 3}, "recommendation": {"P/B": "Neutral", "ROA": "Neutral", "DCF": "Neutral", "P/E": "Neutral", "ROE": "Strong Buy", "D/E": "Sell"}}, "ATOS": {"score": {"P/B": 3, "ROA": 2, "DCF": 5, "P/E": 3, "ROE": 2, "D/E": 5}, "recommendation": {"P/B": "Neutral", "ROA": "Strong Buy", "DCF": "Strong Buy", "P/E": "Neutral", "ROE": "Sell", "D/E": "Sell"}}, "SNDL": {}, "GEVO": {"score": {"P/B": 3, "ROA": 2, "DCF": 3, "P/E": 3, "ROE": 2, "D/E": 3}, "recommendation": {"P/B": "Neutral", "ROA": "Neutral", "DCF": "Neutral", "P/E": "Neutral", "ROE": "Sell", "D/E": "Sell"}}, "PT": {}, "MOTS": {"score": {"P/B": 5, "ROA": 2, "DCF": 4, "P/E": 3, "ROE": 2, "D/E": 4}, "recommendation": {"P/B": "Strong Buy", "ROA": "Buy", "DCF": "Buy", "P/E": "Neutral", "ROE": "Sell", "D/E": "Sell"}}, "BNGO": {}, "ZYXI": {}}}, "enterprise": {"title": "Enterprise History", "data": {"ITRM": {"symbol": "ITRM", "stockPrice": 2.51, "numberOfShares": 14518040, "marketCapitalization": 36440280.4, "minusCashAndCashEquivalents": 4801000, "addTotalDebt": 7625000, "enterpriseValue": 39264280.4}, "DGLY": {"symbol": "DGLY", "stockPrice": 0.97, "numberOfShares": 11478618, "marketCapitalization": 11134259.459999999, "minusCashAndCashEquivalents": 359685, "addTotalDebt": 6500000, "enterpriseValue": 17274574.46}, "ATOS": {"symbol": "ATOS", "stockPrice": 1.44, "numberOfShares": 8496964, "marketCapitalization": 12235628.16, "minusCashAndCashEquivalents": 12581136, "addTotalDebt": 0, "enterpriseValue": -345507.83999999985}, "SNDL": {"addTotalDebt": 16227000, "enterpriseValue": 100372500, "marketCapitalization": 129482500, "minusCashAndCashEquivalents": 45337000, "numberOfShares": 85750000, "stockPrice": 1.51, "symbol": "SNDL"}, "GEVO": {"symbol": "GEVO", "stockPrice": 1.97, "numberOfShares": 12177906, "marketCapitalization": 23990474.82, "minusCashAndCashEquivalents": 16302000, "addTotalDebt": 233000, "enterpriseValue": 7921474.82}, "PT": {"symbol": "PT", "stockPrice": 2.51, "numberOfShares": 40304238, "marketCapitalization": 101163637.38, "minusCashAndCashEquivalents": 102755000, "addTotalDebt": 192872000, "enterpriseValue": 191280637.38}, "MOTS": {"symbol": "MOTS", "stockPrice": 2.02, "numberOfShares": 25133190, "marketCapitalization": 50769043.8, "minusCashAndCashEquivalents": 20528000, "addTotalDebt": 8203000, "enterpriseValue": 38444043.8}, "BNGO": {"symbol": "BNGO", "stockPrice": 1.09, "numberOfShares": 34274469, "marketCapitalization": 37359171.21, "minusCashAndCashEquivalents": 17311373, "addTotalDebt": 0, "enterpriseValue": 20047798.21}, "ZYXI": {"symbol": "ZYXI", "stockPrice": 9.73, "numberOfShares": 32439000, "marketCapitalization": 315631470, "minusCashAndCashEquivalents": 14040000, "addTotalDebt": 0, "enterpriseValue": 301591470}}}, "profile": {"title": "Company Profile", "data": {"ITRM": {"symbol": "ITRM", "price": 1.73, "beta": 0.0, "volAvg": 6382566, "mktCap": 84910128, "lastDiv": 0.0, "range": "0.451-6.02", "changes": 0.43, "companyName": "Iterum Therapeutics PLC", "currency": "USD", "cik": "0001659323", "isin": "IE00BF3W0Q35", "cusip": "G6333L101", "exchange": "NasdaqGM", "exchangeShortName": "NASDAQ", "industry": "Biotechnology", "website": "http://www.iterumtx.com", "description": "Iterum Therapeutics Plc is a pharmaceutical company which engages in the development and commercialization of sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available. The company is headquartered in Dublin, Dublin and currently employs 48 full-time employees. The firm is focused on developing significantly differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens. The firm is developing sulopenem - the oral and intervenous (IV) penem antibiotic demonstrating a potent spectrum of activity against multi-drug resistant gram-negative. The company is a bioavailable, antibiotic covering gram-positive, gram-negative and anaerobic pathogen with in-vitro activity against multidrug-resistant pathogens, including Extended-Spectrum Beta-Lactamase (ESBL)-producing Escherichia, coli and Klebsiella and pneumonia. The company has demonstrated potent in vitro activity against all genera of Enterobacteriacease, in anaerobes such as Bacteroides, Prevotella, Porphyromonas, Fusobacterium and Peptostreptococcus, gram-positive organisms including methicillin-susceptible staphylococci, Streptococcus pyogenes and Streptococcus pneumonia.", "ceo": "Mr. Corey Fishman", "sector": "Healthcare", "country": "IE", "fullTimeEmployees": "44", "phone": "8722256077", "address": "Block 2 Floor 3, Harcourt Centre, Harcourt Street", "city": "DUBLIN", "state": "DUBLIN", "zip": "2", "dcfDiff": null, "dcf": 1.51069, "image": "https://financialmodelingprep.com/image-stock/ITRM.png", "ipoDate": "2018-05-25", "defaultImage": false}, "DGLY": {"symbol": "DGLY", "price": 2.665, "beta": 0.62727, "volAvg": 6657866, "mktCap": 80175728, "lastDiv": 0.0, "range": "0.64-7.1", "changes": -0.315, "companyName": "Digital Ally Inc", "currency": "USD", "cik": "0001342958", "isin": "US25382P2083", "cusip": "25382P208", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Security & Protection Services", "website": "http://www.digitalallyinc.com/", "description": "Digital Ally, Inc. produces and sells digital video imaging and storage products for use in law enforcement, security, and commercial applications in the United States and internationally. Its digital audio/video recording, storage, and other products include an in-car digital audio/video recorder that is contained in a rear view mirror for law enforcement vehicles and commercial fleets; and hands-free automatic activated body-worn cameras and in-car video systems, as well as provides its law enforcement customers with audio/video surveillance from multiple vantage points. The company also provides VuLink, an in-car device that enables an in-car and body worn digital audio/video camera system to automatically and simultaneously start recording; and Digital Ally, a suite of data management Web-based tools to assist fleet managers in the organization, archival, and management of videos and telematics information. In addition, its digital audio/video recording, storage, and other products comprise a miniature body-worn digital video system; VuVault.net, a law enforcement cloud storage solution, including cloud-based fleet management and driver monitoring/training applications; and FleetVU Manager, a Web-based software for commercial fleet tracking and monitoring. The company sells its products through direct sales and third-party distributors. Digital Ally, Inc. is headquartered in Lenexa, Kansas.", "ceo": "Mr. Stanton Ross", "sector": "Industrials", "country": "US", "fullTimeEmployees": "119", "phone": "19132325349", "address": "9705 Loiret Blvd", "city": "Lenexa", "state": "KANSAS", "zip": "66219", "dcfDiff": -8.43, "dcf": 2.16134, "image": "https://financialmodelingprep.com/image-stock/DGLY.png", "ipoDate": "2005-02-22", "defaultImage": false}, "ATOS": {"symbol": "ATOS", "price": 1.495, "beta": 2.45985, "volAvg": 6432364, "mktCap": 106741208, "lastDiv": 0.0, "range": "0.76-5.08", "changes": 0.085, "companyName": "Atossa Therapeutics Inc", "currency": "USD", "cik": "0001488039", "isin": "US04962H5063", "cusip": "04962H506", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Biotechnology", "website": "https://atossatherapeutics.com/", "description": "Atossa Therapeutics, Inc. develops and markets medical devices, laboratory tests, and therapeutics to address breast health conditions in the United States. The company's lead program is the development of Endoxifen, an active metabolite of tamoxifen which is in Phase II studies to treat and prevent breast cancer. It is also developing intraductal microcatheter technology to target the delivery of therapies, including fulvestrant, immunotherapies, and Chimeric Antigen Receptor T-cell therapies, directly to the site of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2009 and is headquartered in Seattle, Washington.", "ceo": "Dr. Steven Quay", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "4", "phone": "12065880256", "address": "107 Spring St", "city": "Seattle", "state": "WASHINGTON", "zip": "98104", "dcfDiff": -3.47, "dcf": 3.36066, "image": "https://financialmodelingprep.com/image-stock/ATOS.png", "ipoDate": "2012-11-08", "defaultImage": false}, "SNDL": {"symbol": "SNDL", "price": 0.6806, "beta": 0.0, "volAvg": 312177977, "mktCap": 755289020, "lastDiv": 0.0, "range": "0.138-3.65", "changes": -0.0094, "companyName": "Sundial Growers Inc", "currency": "CAD", "cik": "0001766600", "isin": "CA86730L1094", "cusip": "86730L109", "exchange": "NasdaqGS", "exchangeShortName": "NASDAQ", "industry": "Drug Manufacturers General Specialty & Generic", "website": "https://www.sundialcannabis.com/", "description": "Sundial Growers Inc. engages in the production, distribution, and sale of cannabis products for the adult-use market It is also involved in the production, distribution, and sale of ornamental plants and herbs in the United Kingdom. The company offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. Sundial Growers Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.", "ceo": "Mr. Zachary Ryan George IV", "sector": "Healthcare", "country": "CA", "fullTimeEmployees": "868", "phone": "14039485227", "address": "919 11 Ave SW Suite 200", "city": "Calgary", "state": "ALBERTA", "zip": "T2R 1P3", "dcfDiff": null, "dcf": null, "image": "https://financialmodelingprep.com/image-stock/SNDL.jpg", "ipoDate": "2019-08-01", "defaultImage": true}, "GEVO": {"symbol": "GEVO", "price": 8.8011, "beta": 2.79711, "volAvg": 27164359, "mktCap": 1132155900, "lastDiv": 0.0, "range": "0.46-11.68", "changes": -2.2289, "companyName": "Gevo Inc", "currency": "USD", "cik": "0001392380", "isin": "US3743964062", "cusip": "374396406", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Specialty Chemicals", "website": "http://www.gevo.com/", "description": "Gevo, Inc. is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. The company is headquartered in Englewood, Colorado and currently employs 52 full-time employees. The firm has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock. The company has two operating segments: the Gevo, Inc. segment and the Gevo Development/Agri-Energy segment. Its Gevo, Inc. segment is responsible for research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Its Gevo Development/Agri-Energy segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.", "ceo": "Dr. Patrick Gruber", "sector": "Basic Materials", "country": "US", "fullTimeEmployees": "53", "phone": "13038588358", "address": "Building C, 345 Inverness Dr S Ste 310", "city": "Englewood", "state": "COLORADO", "zip": "80112", "dcfDiff": -11084.8, "dcf": 2.43865, "image": "https://financialmodelingprep.com/image-stock/GEVO.png", "ipoDate": "2011-02-09", "defaultImage": false}, "PT": {"symbol": "PT", "price": 1.1799, "beta": 0.0, "volAvg": 274830, "mktCap": 50898884, "lastDiv": 0.0, "range": "0.75-3.23", "changes": -0.0101, "companyName": "Pintec Technology Holdings Ltd", "currency": "CNY", "cik": "0001716338", "isin": "US72352G1076", "cusip": "72352G107", "exchange": "NasdaqGM", "exchangeShortName": "NASDAQ", "industry": "Credit Services", "website": "https://www.pintec.com", "description": "Pintec Technology Holdings Ltd. engages in the provision of financial services through technology platform. The company is headquartered in Beijing, Beijing and currently employs 362 full-time employees. The firm is located in China.", "ceo": "Mr. Jun Dong", "sector": "Financial Services", "country": "CN", "fullTimeEmployees": "256", "phone": "861085643600", "address": "9/F Heng An Building, No.17 East 3Rd Ring Road", "city": "Beijing", "state": "BEIJING", "zip": null, "dcfDiff": null, "dcf": 10.1899, "image": "https://financialmodelingprep.com/image-stock/PT.png", "ipoDate": "2018-10-25", "defaultImage": false}, "MOTS": {"symbol": "MOTS", "price": 1.89, "beta": 2.069734, "volAvg": 698095, "mktCap": 60936244, "lastDiv": 0.0, "range": "0.46-2.3", "changes": 0.14, "companyName": "Motus GI Holdings Inc", "currency": "USD", "cik": "0001686850", "isin": "US62014P1084", "cusip": "62014P108", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Diagnostics & Research", "website": "https://www.motusgi.com/", "description": "Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 44 full-time employees. The firm is developing Pure-Vu system that integrates with existing colonoscopes to cleanse poorly prepped colons during the colonoscopy procedure. The Pure-Vu system uses a precise mixture of water and air to loosen debris from the colon mucosa while simultaneously evacuating the bowel contents, clearing the way for the endoscopist to perform a high quality examination, even when the patient is not fully clean prior to their procedure. The Pure-Vu System also helps in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon This device fits standard colonoscopes, allowing the physician to clean poorly-prepped colons in a safe and effective manner to gain clear visualization of the colon mucosa.", "ceo": "Mr. Timothy Moran", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "49", "phone": "17864591831", "address": "1301 E Broward Blvd Fl 3", "city": "Fort Lauderdale", "state": "FLORIDA", "zip": "33301", "dcfDiff": null, "dcf": 0.0, "image": "https://financialmodelingprep.com/image-stock/MOTS.png", "ipoDate": "2018-02-14", "defaultImage": false}, "BNGO": {"symbol": "BNGO", "price": 7.905, "beta": 0.0, "volAvg": 65234906, "mktCap": 1798245250, "lastDiv": 0.0, "range": "0.25-9.95", "changes": -1.235, "companyName": "Bionano Genomics Inc", "currency": "USD", "cik": "0001411690", "isin": "US09075F1075", "cusip": "09075F107", "exchange": "NasdaqCM", "exchangeShortName": "NASDAQ", "industry": "Diagnostics & Research", "website": "https://bionanogenomics.com/", "description": "BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The company is headquartered in San Diego, California and currently employs 77 full-time employees. The firm develops and markets the Saphyr system. The Company\u2019s products include Sequencing for Discovery Research and Cytogenetics. Sequencing alone, however, is significantly limited due to its inability to reveal structural variations. Cytogenetics provide a clinical diagnosis, cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response.", "ceo": "DR. R. Erik Holmlin", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "97", "phone": "18588887600", "address": "9540 Towne Centre Dr Ste 100", "city": "San Diego", "state": "CALIFORNIA", "zip": "92121", "dcfDiff": null, "dcf": null, "image": "https://financialmodelingprep.com/image-stock/BNGO.png", "ipoDate": "2018-08-01", "defaultImage": false}, "ZYXI": {"symbol": "ZYXI", "price": 17.5, "beta": 0.67852, "volAvg": 530829, "mktCap": 608772480, "lastDiv": 0.0, "range": "7.93-29.73", "changes": -0.55, "companyName": "Zynex Inc", "currency": "USD", "cik": "0000846475", "isin": "US98986M1036", "cusip": "98986M103", "exchange": "NasdaqCM", "exchangeShortName": "NASDAQ", "industry": "Medical Devices", "website": "https://www.zynex.com/", "description": "Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device. The company also supplies electrodes for the delivery of electrical current to the body and batteries for use in electrotherapy products; and distributes Comfortrac for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers blood volume monitor, a non-invasive medical device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.", "ceo": "Mr. Thomas Sandgaard", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "283", "phone": "13038673904", "address": "9555 MAROON CIRCLE", "city": "Englewood", "state": "COLORADO", "zip": "80112", "dcfDiff": null, "dcf": 14.1834, "image": "https://financialmodelingprep.com/image-stock/ZYXI.jpg", "ipoDate": "2002-11-27", "defaultImage": true}}}, "news": ["https://www.fool.com/investing/2021/01/20/why-gevo-stock-was-sinking-today/", "https://www.fool.com/investing/2021/01/20/why-bionano-genomics-stock-is-down-today/", "https://www.marketwatch.com/story/bionano-genomics-prices-200-million-underwritten-stock-offering-at-a-discount-of-6-a-share-2021-01-20", "https://www.globenewswire.com/news-release/2021/01/20/2161341/0/en/Bionano-Genomics-Announces-Pricing-of-200-Million-Underwritten-Public-Offering-of-Common-Stock.html", "https://www.marketwatch.com/story/gevo-shares-slide-20-premarket-on-news-of-350-million-stock-offering-2021-01-20"]}